| Applications: |
Immunodepletion/Immunocompetition |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Dopamine D5 Receptor Blocking Peptide is synthetically produced from the sequence and is suitable for use in western blot applications. |
| Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: |
DRD5 |
| Gene ID: |
1816 |
| Uniprot ID: |
DRD5_HUMAN |
| Immunogen: |
Synthetic peptide corresponding to unique sequence on Dopamine Receptor D5 protein. |
| Tissue Specificity | Neuron-specific, localized primarily within limbic regions of the brain. |
| Function | Dopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase. |
| Peptide Name | D(1b Dopamine ReceptorD(5 Dopamine ReceptorD1beta Dopamine ReceptorDopamine D5 Receptor |
| Database Links | Reactome: R-HSA-390651Reactome: R-HSA-418555 |
| Cellular Localisation | Cell MembraneMulti-Pass Membrane Protein |
| Alternative Peptide Names | D(1b Dopamine Receptor proteinD(5 Dopamine Receptor proteinD1beta Dopamine Receptor proteinDopamine D5 Receptor proteinDRD5 proteinDRD1B proteinDRD1L2 protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
